Subependymoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 112: Line 112:
*Little or no enhancement
*Little or no enhancement
|}
|}
==Other Imaging Findings==
===Magnetic Resonance Spectroscopy===
*[[Nuclear magnetic resonance spectroscopy|MR spectroscopy]] may be helpful in the diagnosis of protoplasmic astrocytoma, which demonstrates elevated [[choline]]/[[creatine]] ratio.<ref name=radiologicalfeaturspa1>Radiological features of protoplasmic astrocytoma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/protoplasmic-astrocytoma. Accessed on January 8, 2016</ref>
===Magnetic Resonance Perfusion===
*[[Perfusion weighted imaging|MR perfusion]] may be helpful in the diagnosis of protoplasmic astrocytoma, which demonstrates no elevation of relative cerebral blood volume (rCBV).<ref name=radiologicalfeaturspa1>Radiological features of protoplasmic astrocytoma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/protoplasmic-astrocytoma. Accessed on January 8, 2016</ref>
==Electroencephalogram==
*[[Electroencephalogram|Electroencephalogram (EEG)]] is performed in cases of protoplasmic astrocytoma to record the continuous electrical activity of the brain and locate the seizure activity.<ref name=radfa1>Radiographic features of fibrillary astrocytoma. Dr Henry Knipe and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/fibrillary-astrocytoma. Accessed on January 4, 2016</ref>


==Biopsy==
==Biopsy==
*[[Biopsy]] of the protoplasmic astrocytoma tumor, taken through a needle during a simple surgical procedure, helps to confirm the diagnosis.<ref name=treatmentandprognosispa1>Treatment and prognosis of protoplasmic astrocytoma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/protoplasmic-astrocytoma. Accessed on January 8, 2016</ref>
*[[Biopsy]] of the subependymoma tumor, taken through a needle during a simple surgical procedure, helps to confirm the diagnosis.<ref name=diagnosisse1>Diagnosis of subependymoma. Wikipedia 2016. https://en.wikipedia.org/wiki/Subependymoma. Accessed on January 8, 2016</ref>


==Treatment==
==Treatment==
*The treatment of protoplasmic astrocytoma depends on the clinical presentation, tumor size, and location.<ref name=treatmentandprognosispa1>Treatment and prognosis of protoplasmic astrocytoma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/protoplasmic-astrocytoma. Accessed on January 8, 2016</ref>
:*'''Surgery''': The predominant therapy for protoplasmic astrocytoma is [[surgery|surgical resection]].<ref name=treatmentandprognosispa1>Treatment and prognosis of protoplasmic astrocytoma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/protoplasmic-astrocytoma. Accessed on January 8, 2016</ref>
:*'''Radiotherapy''': [[Radiotherapy]] may be used in protoplasmic astrocytoma post-operatively or at the time of recurrence or progression.<ref name=biopsyga1>Treatment and prognosis of low grade infiltrative astrocytoma. Dr Ahmed Abd Rabou and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/low-grade-infiltrative-astrocytoma. Accessed on January 8, 2016</ref>
:*'''Chemotherapy''': [[Chemotherapy]] may have a role in recurrent and de-differentiated tumors.<ref name=biopsyga1>Treatment and prognosis of low grade infiltrative astrocytoma. Dr Ahmed Abd Rabou and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/low-grade-infiltrative-astrocytoma. Accessed on January 8, 2016</ref>




{{familytree/start |summary=Treatment of protoplasmic astrocytoma}}
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | | | | | | | A01| | | | | | | | | | | | | |A01=<div style="width: 12em; padding:0.2em;">'''Treatment of protoplasmic astrocytoma'''</div>}}
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | |,|-|-|-|-|-|+|-|-|-|-|-|.| | | | | | | | | | | | | | |}}
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | B01 | | | | B02 | | | | B03 | | | | | | | | | | | | | |B01=<div style="width: 9em; padding:0.2em;">'''Surgery''' </div>|B02=<div style="width: 9em; padding:0.2em;">'''Radiotherapy'''</div>|B03=<div style="width: 9em; padding:0.2em;">'''Chemotherapy'''</div>}}
{{familytree/end}}


==References==
==References==

Revision as of 18:23, 12 January 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Synonyms and keywords: Subependymomas

Overview

Subependymoma is a type of the brain tumor; specifically, it is a rare form of ependymal tumor.[1] Subependymoma is a benign (WHO grade I) tumor, which is slow growing and non-invasive.[2]

Pathophysiology

Gross Pathology

  • Subependymoma is most commonly seen in the fourth ventricle, but can arise anywhere where there is ependyma. The distribution in the ventricular system is as follows:[3]
  • On gross pathology, subependymoma is characterized by a small, well circumscribed mass attached to the ventricular wall by a narrow pedicle.

Microscopic Pathology

  • On microscopic histopathological analysis, subependymoma is characterized by microcystic spaces and bland appearing cells without appreciable nuclear atypia or mitoses. The nuclei tend to form clusters.

Immunohistochemistry

  • Subependymoma is demonstrated by positivity to tumor marker such as GFAP.[3]

Differentiating Protoplasmic Astrocytoma from other Diseases

Epidemiology and Demographics

Age

  • Subependymoma is a rare disease that tends to affect middle-aged adults and the elderly population (typically 5th to 6th decades).[5]

Gender

  • Males are more commonly affected with subependymoma than females. The male to female ratio is approximately 2.3 to 1.[5]

Natural History, Complications and Prognosis

Natural History

Complications

  • Common complication of subependymoma include:[6]

History and Symptoms

History

  • When evaluating a patient for subependymoma, you should take a detailed history of the presenting symptom (onset, duration, and progression), other associated symptoms, and a thorough family and past medical history review.

Symptoms

  • Typically patients of subependymoma are asymptomatic and small lesions are discovered incidentally.
  • Symptoms of subependymoma include:[7]

CT

  • Head CT scan is helpful in the diagnosis of subependymoma. On CT scan, subependymoma is characterized by:
Iso- and hypodense intraventricular mass
  • Positive mass effect
  • No enhancement
  • If large, it may have cystic or even calcific components
  • No vasogenic edema

MRI

  • Brain MRI is helpful in the diagnosis of subependymoma. On MRI, subependymoma is characterized by:
MRI component Findings

T1

  • Iso - hypointense compared to white matter
  • Homogeneous but may be heterogeneous in larger lesions

T2

  • Hyperintense compared to adjacent white and grey matter
  • Heterogeneity may be seen in larger lesions, with susceptibility related signal drop out due to calcifications
  • No adjacent parenchymal edema (as no brain invasion is present)

Fluid-attenuated inversion recovery (FLAIR)

  • Large areas of T2 hyperintensity suppress on FLAIR
  • These are not macrocystic, but rather represent the areas with abundant microcystic change)

T1 with contrast

  • Little or no enhancement

Biopsy

  • Biopsy of the subependymoma tumor, taken through a needle during a simple surgical procedure, helps to confirm the diagnosis.[8]

Treatment

References

  1. Subependymoma. Wikipedia 2016. https://en.wikipedia.org/wiki/Subependymoma. Accessed on January 12, 2016
  2. Subependymoma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/subependymoma. Accessed on January 12, 2016
  3. 3.0 3.1 Pathology of subependymoma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/subependymoma. Accessed on January 12, 2016
  4. Intraventricular neoplasms and lesions. Dr Henry Knipe and Dr Vinod G Maller et al. Radiopaedia 2016. http://radiopaedia.org/articles/intraventricular-neoplasms-and-lesions. Accessed on January 12, 2016
  5. 5.0 5.1 Epidemiology of subependymoma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/subependymoma. Accessed on January 12, 2016
  6. 6.0 6.1 Clinical presentation of subependymoma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/subependymoma. Accessed on January 12, 2016
  7. KE, Changshu. "Subependymoma: a case report and the review of literatures". doi:10.3969/j.issn.1672-6731.2011.01.021.
  8. Diagnosis of subependymoma. Wikipedia 2016. https://en.wikipedia.org/wiki/Subependymoma. Accessed on January 8, 2016

Template:WH Template:WS